|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330.20 CHF | +0.98% |
|
-1.40% | +0.61% |
| 10:57am | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 06:40am | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 323B | AA | ||||||||
| 1,028B | A | ||||||||
| 611B | BBB | ||||||||
| 432B | AA | - | |||||||
| 277B | AAA | ||||||||
| 257B | A | ||||||||
| 217B | A | ||||||||
| 192B | A | ||||||||
| 161B | AA | ||||||||
| 138B | A | ||||||||
| 121B | AA | ||||||||
| 116B | A | ||||||||
| 104B | AA | ||||||||
| 103B | AA | ||||||||
| 73.58B | AA | ||||||||
| 55.22B | AA | ||||||||
| 53.42B | AA | ||||||||
| 51.97B | AA | ||||||||
| 42.52B | AA | ||||||||
| 37.55B | AA | ||||||||
| Average | 219.71B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Stocks
- ROP Stock
- Sector Roche Holding AG
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















